Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for Tom Johnson�
83.56
+1.35 (1.64%)
Real-time:   12:36PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 83.12 - 83.90
52 week 66.80 - 87.00
Open 83.12
Vol / Avg. 530,505.00/1.49M
Mkt cap 16.88B
P/E 26.17
Div/yield 0.38/1.80
EPS 3.19
Shares 202.00M
Beta 0.74
Inst. own 95%
May 1, 2014
Mead Johnson Nutrition Annual Shareholder Meeting - 10:00AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Mead Johnson Nutrition Earnings Release - 9:30AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Mead Johnson Nutrition Earnings Conference Call - 9:30AM EDT - Add to calendar
Feb 20, 2014
Mead Johnson Nutrition at CAGNY Conference - Webcast
Jan 31, 2014
Q4 2013 Mead Johnson Nutrition Earnings Conference Call - Webcast
Jan 31, 2014
Q4 2013 Mead Johnson Nutrition Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 14.78% 15.59%
Operating margin 18.24% 20.81%
EBITD margin - 26.22%
Return on average assets 18.42% 19.46%
Return on average equity 244.49% 417.58%
Employees 7,200 -
CDP Score - 85 B

Address

2701 PATRIOT BOULEVARD
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its Enfa family of brands, including Enfamil infant formula, is the global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe. During the year ended December 31, 2011, it operated two segments: Asia/Latin America and North America/Europe, which consisted of 66% and 34%, respectively, of its net sales. In addition to the Enfa family of brands, the Company markets several other brands on a local, regional or global basis.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Peter G. Leemputte Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
William C. P'Pool Senior Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
Dirk H Hondmann Ph.D. Senior Vice President - Global Research and Development
Age: 49
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Global Supply Chain
Age: 53
Bio & Compensation  - Reuters
Charles M. Urbain Senior Vice President - Stakeholder Relations & Chief Development Officer
Age: 59
Bio & Compensation  - Reuters
Tom De Weerdt Vice President, Corporate Controller
Age: 40
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Robert Steven Singer Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 59
Bio & Compensation  - Reuters